Anesth Pain Med.  2017 Jul;12(3):281-285. 10.17085/apm.2017.12.3.281.

Perioperative anesthetic management of a patient with catecholamine-secreting paraganglioma: A case report

• Park SL
• Rhyu CJ
• Kim KI
• Chon SW
• Kim TW
• Koh JW

• KMID: 2388848
• DOI: http://doi.org/10.17085/apm.2017.12.3.281

Abstract

Paraganglioma is an uncommon neuroendocrine tumor of cells that originate in the autonomic nervous system. Some paragangliomas have the ability to secrete catecholamines, similar to secretions in pheochromocytoma. For this reason, paragangliomas may cause malignant hypertension in patient, upon being administered anesthesia, or during surgery, this may lead to a life-threatening condition, despite the tumor having been diagnosed before conducting the procedure. Therefore, it is important to take adequate actions for reducing the occurrence of morbidity and mortality during surgery. Here, we describe a successful anesthetic management in a patient diagnosed with retroperitoneal paraganglioma invading the iliac bone.

Keyword

Catecholamines; Embolization; Malignant hypertension; Paraganglioma

MeSH Terms

Anesthesia
Autonomic Nervous System
Catecholamines
Humans
Hypertension, Malignant
Mortality
Neuroendocrine Tumors
Paraganglioma*
Pheochromocytoma
Catecholamines

Figure

• 

  Fig. 1 Transverse T2-weighted magnetic resonance image showing large bone destructing mass in left iliac bone with adjacent muscle invasion.

• 

  Fig. 2 Pelvic aortography showed large tumor staining in left pelvic area via lower most left lumbar artery, internal iliac branches.

• 

  Fig. 3 Follow-up computed tomography scan showing increased mass in left ilium.

Reference

1. Ahmad S, Cathy D, Sheikh M, Sweeney P. Retroperitoneal extra-adrenal paraganglioma: a rare but important diagnosis. Ir J Med Sci. 2009; 178:211–4. DOI: 10.1007/s11845-007-0113-z. PMID: 18183473.

2. Somasundar P, Krouse R, Hostetter R, Vaughan R, Covey T. Paragangliomas--a decade of clinical experience. J Surg Oncol. 2000; 74:286–90. DOI: 10.1002/1096-9098(200008)74:4<286::AID-JSO9>3.0.CO;2-C.

3. Young WF Jr. Paragangliomas: clinical overview. Ann N Y Acad Sci. 2006; 1073:21–9. DOI: 10.1196/annals.1353.002. PMID: 17102068.

4. Renard J, Clerici T, Licker M, Triponez F. Pheochromocytoma and abdominal paraganglioma. J Visc Surg. 2011; 148:e409–16. DOI: 10.1016/j.jviscsurg.2011.07.003. PMID: 21862435.

5. Koumaras Ch, Anagnostis P, Tzimou M, Giavanidis I, Gossios T, Antoniadis A, et al. Paraganglioma in a young patient with asymptomatic severe hypertension: a case report and review of the literature. Hippokratia. 2010; 14:300–2. PMID: 21311646. PMCID: PMC3031332.

6. Waguespack SG, Rich T, Grubbs E, Ying AK, Perrier ND, Ayala-Ramirez M, et al. A current review of the etiology, diagnosis, and treatment of pediatric pheochromocytoma and paraganglioma. J Clin Endocrinol Metab. 2010; 95:2023–37. DOI: 10.1210/jc.2009-2830. PMID: 20215394.

7. Lee JA, Duh QY. Sporadic paraganglioma. World J Surg. 2008; 32:683–7. DOI: 10.1007/s00268-007-9360-4. PMID: 18224469.

8. Kinney MA, Narr BJ, Warner MA. Perioperative management of pheochromocytoma. J Cardiothorac Vasc Anesth. 2002; 16:359–69. DOI: 10.1053/jcan.2002.124150. PMID: 12073213.

9. Di Daniele N, Canale MP, Tesauro M, Rovella V, Gandini R, Schillaci O, et al. Preoperative embolization reduces the risk of cathecolamines release at the time of surgical excision of large pelvic extra-adrenal sympathetic paraganglioma. Case Rep Endocrinol. 2012; 2012:481328. DOI: 10.1155/2012/481328.

10. Arai T, Hatano Y, Ishida H, Mori K. Use of nicardipine in the anesthetic management of pheochromocytoma. Anesth Analg. 1986; 65:706–8. DOI: 10.1213/00000539-198606000-00027. PMID: 3706810.

11. Jeon HH, Chung RK, Lee H, Kim JH, Baik HJ, Han JI. Hypertensive crisis during percutaneous radiofrequency ablation of a metastatic adrenal tumor under general anesthesia: A case report. Anesth Pain Med. 2014; 9:70–2.

12. Park SY. Perioperative management of cardiovascular medication. Anesth Pain Med. 2014; 9:153–8.